A bill to overhaul the Drugs and Cosmetics Act, 1940 faces stiff opposition from the medical device and pharma sectors for being drafted without stakeholder consultation and for criminalizing minor technical errors, contrary to the government's own Jan Vishwas Bill that decriminalized such offences. This highlights tensions between regulatory reform and ease of doing business.
Exam Lens
Quick Exam Facts From News
1-Minute Revision
- ›Act Being Overhauled: Drugs and Cosmetics Act, 1940
- ›Bill First Circulated: 2022-23
- ›Target this Act: Drugs and Cosmetics Act, 1940
- ›Target this Bill: Overhaul bill (same as 2022-23 draft)
- ›Target this Contrast: Jan Vishwas Bill (decriminalization vs criminalization)
Mastered this topic? Test your knowledge with a full MCQ quiz.
Practice exam-style questions, track your score, and strengthen your recall.